154 related articles for article (PubMed ID: 38618144)
1. Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study.
Huang H; Liao W; Zhang K; Wang H; Cheng Q; Mei B
J Hepatocell Carcinoma; 2024; 11():721-735. PubMed ID: 38618144
[TBL] [Abstract][Full Text] [Related]
2. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma.
Wang H; Yu H; Qian YW; Cao ZY; Wu MC; Cong WM
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):232-239. PubMed ID: 33455865
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
Chen W; Hu S; Liu Z; Sun Y; Wu J; Shen S; Peng Z
Hepatol Int; 2023 Apr; 17(2):406-416. PubMed ID: 36645648
[TBL] [Abstract][Full Text] [Related]
4. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
Zhang XP; Liu YC; Chen ZH; Sun JX; Wang K; Chai ZT; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2019 May; 26(5):1465-1473. PubMed ID: 30767178
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
Zhang YL; Nie CH; Chen F; Zhou TY; Zhou GH; Zhu TY; Chen SQ; Chen XH; Wang HL; Wang BQ; Yu ZN; Jing L; He ZM; Sun JH
Front Oncol; 2020; 10():1754. PubMed ID: 32984060
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study.
Yuan L; Feng J; Zhang Y; Lu C; Xu L; Liang C; Liu Z; Mao F; Xiang Y; Wang W; Wang K; Cheng S
Eur J Surg Oncol; 2023 Jul; 49(7):1226-1233. PubMed ID: 36739252
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
9. Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study.
Huang Q; Lin K; Wang L; Zeng J; Liu H; Ding Z; Zeng Y; Liu J
Cancer Manag Res; 2020; 12():9183-9195. PubMed ID: 33061610
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of postoperative adjuvant transcatheter arterial chemoembolization based on the neutrophil-to-lymphocyte ratio.
Feng GY; Shi ZR; Zhao YF; Chen K; Tao J; Wei XF; Cheng Y
Front Surg; 2022; 9():1072451. PubMed ID: 36684128
[TBL] [Abstract][Full Text] [Related]
11. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
Liu S; Li H; Guo L; Zhang B; Zhou B; Zhang W; Zhou J; Fan J; Ye Q
Oncologist; 2019 Apr; 24(4):513-520. PubMed ID: 30552155
[TBL] [Abstract][Full Text] [Related]
12. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
Ke Q; Xiang F; Xiao C; Huang Q; Liu X; Zeng Y; Wang L; Liu J
BMC Cancer; 2021 Oct; 21(1):1117. PubMed ID: 34663242
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Versus Postoperative Transarterial Chemoembolization on Prognosis of Large Hepatocellular Carcinoma.
Wang X; Yuan Y; Wang J; Liu Z; Chen M; Zhou Q; Zhou Z
J Cancer; 2021; 12(20):6231-6241. PubMed ID: 34539896
[No Abstract] [Full Text] [Related]
14. Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy.
Feng LH; Zhu YY; Zhou JM; Wang M; Xu WQ; Zhang T; Mao AR; Cong WM; Dong H; Wang L
Front Oncol; 2023; 13():1104492. PubMed ID: 37293583
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
Wu Z; Cui L; Qian J; Luo L; Tu S; Cheng F; Yuan L; Zhang W; Lin W; Tang H; Li X; Li H; Zhang Y; Zhu J; Li Y; Xiong Y; Hu Z; Peng P; He Y; Liu L; He K; Shen W
BMC Cancer; 2023 Apr; 23(1):325. PubMed ID: 37029339
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.
Xu JX; Qin SL; Wei HW; Chen YY; Peng YC; Qi LN
Ann Med; 2023 Dec; 55(1):2199219. PubMed ID: 37070467
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion.
Qiu Y; Yang Y; Wang T; Shen S; Wang W
Front Oncol; 2022; 12():831614. PubMed ID: 35795039
[TBL] [Abstract][Full Text] [Related]
19. Association of CK19 expression with the efficacy of adjuvant transarterial chemoembolization after hepatic resection in hepatocellular carcinoma patients at high risk of recurrence.
Wu MS; Zhong JH; Chen K; Luo CP; Zhang J; Zhou YJ; Ma Y; Xiang BD
J Clin Transl Res; 2022 Feb; 8(1):71-79. PubMed ID: 35224238
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study.
Zeng G; Zou B; Li Y; Lin E; Liu X; Li P; Chen J; Zhang B; Jia Y; Cai C; Li J
J Invest Surg; 2022 Jun; 35(6):1208-1216. PubMed ID: 35078386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
